Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 527 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 85% confidence The document is a compliance submission under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (Regulation 31(4)), declaring no encumbrance/pledge of shares by the Promoter and Promoter Group. It does not present financial statements or report results, nor does it announce voting, dividends, or capital changes. It is a regulatory disclosure for record‐keeping. This falls under “Regulatory Filings” (RNS), the catch‐all category for compliance documents and miscellaneous regulatory announcements.
2026-06-02 English
Annual Secretarial Compliance Report for the Financial Year 2025-26.
Regulatory Filings Classification · 90% confidence The document is a letter from Rossari Biotech to the stock exchanges enclosing the Annual Secretarial Compliance Report issued by a Practising Company Secretary under SEBI LODR Regulation 24A for FY ended March 31, 2026. It is a statutory compliance certificate/attestation rather than a full financial report, board change notice, or earnings release. Under the certification rule, such officer certifications and regulatory compliance filings are classified as Regulatory Filings (RNS).
2026-05-29 English
Options to purchase securities
Board/Management Information Classification · 90% confidence The document is an official notice under SEBI Listing Regulations announcing the outcome of the Board meeting held on May 27, 2026. It details the re-appointment of a Non-Executive Independent Director and the grant of ESOP options, both of which are decisions made by and announced from the Board. There are no substantive financial statements or earnings guidance; rather, this is a corporate governance and board approval announcement. Therefore, it fits the “Board/Management Information” category.
2026-05-27 English
Intimation of grant of 830050 options under Rossari Employee Stock Option Plan- 2019.
Board/Management Information Classification · 83% confidence The document is a SEBI Listing Regulation compliance announcement detailing the outcome of a Board Meeting, specifically the re-appointment of an Independent Director and grant of stock options. It is not a full financial report or earnings release, but a management and board change notice. Therefore it falls under Board/Management Information.
2026-05-27 English
Re-appointment of Ms. Esha Padmanabhan Achan (DIN:10350369), as a Non-Executive Independent Director of the Company.
Board/Management Information Classification · 85% confidence The document is an outcome of a Board Meeting, detailing the re-appointment of an Independent Director and the grant of ESOP options. It is a regulatory compliance announcement under SEBI LODR Regulation 30 but is not an earnings release or financial report. It specifically announces board/management changes, fitting the Board/Management Information category.
2026-05-27 English
Appointment
Board/Management Information Classification · 95% confidence The document is a stock exchange disclosure of the outcome of a Board Meeting, primarily announcing the re-appointment of an Independent Director and ESOP option grants. This is a board/management change announcement rather than a full report, financial supplement, or other category. Therefore, it fits “Board/Management Information (MANG)”.
2026-05-27 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.